The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up

Claudio Ponticelli, Luigi Minetti, Filippo Quarto Di Palo, Antonio Vegeto, Lino Belli, Giuseppe Corbetta, Antonino Tarantino, Giovanni Civati

Research output: Contribution to journalArticle

Abstract

Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76% for CsA patients and 48% for Aza patients (P

Original languageEnglish
Pages (from-to)908-913
Number of pages6
JournalTransplantation
Volume45
Issue number5
Publication statusPublished - 1988

    Fingerprint

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Ponticelli, C., Minetti, L., Quarto Di Palo, F., Vegeto, A., Belli, L., Corbetta, G., Tarantino, A., & Civati, G. (1988). The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up. Transplantation, 45(5), 908-913.